Skip to main content
A

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2023-07-27 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
First Cannabinoid Medicines Launched
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the London Stock Exchange's Regulatory News Service (RNS). It announces the launch of new cannabinoid medicines by Ananda Developments PLC. It does not fit into specific categories like financial reports, board changes, or dividend notices. As it is a general corporate announcement regarding business operations and product launches, it falls under the 'Regulatory Filings' (RNS) category.
2023-07-27 English
Unaudited Preliminary Results
Earnings Release Classification · 95% confidence The document is an 'Unaudited Preliminary Results' announcement for the year ended 31st January 2023. It contains key financial highlights, a Chairman's statement, and condensed financial statements (Income, Position, Changes in Equity, Cash Flows). While it contains financial data, it is explicitly labeled as an RNS (Regulatory News Service) announcement and serves as the initial release of financial results rather than a full, audited Annual Report (10-K). According to the filing definitions, an initial announcement of periodic financial results is classified as an Earnings Release (ER). FY 2023
2023-07-13 English
Operational Update
Regulatory Filings Classification · 98% confidence The document is an 'Operational Update' issued by Ananda Developments PLC via an RNS (Regulatory News Service). It provides a narrative update on business operations, research progress, and commercial activities, alongside a specific section regarding the 'Exercise of Options' and 'Total Voting Rights'. While it contains operational details, it is a general corporate announcement rather than a formal financial report, management discussion, or specific shareholder meeting document. Given the mix of operational news and regulatory disclosure, it fits best as a general regulatory filing.
2023-06-26 English
Research Round Up
Regulatory Filings Classification · 98% confidence The document is a 'Medical Cannabis Research Roundup' issued by Ananda Developments PLC via the RNS (Regulatory News Service) platform. It provides a summary of external scientific research papers related to cannabinoid medicines. It does not contain financial results, governance updates, or mandatory regulatory disclosures, but rather serves as a corporate communication/press release regarding industry research. As it does not fit into specific categories like 10-K, IR, or ER, and is distributed via RNS, it falls under the 'Regulatory Filings' fallback category.
2023-06-23 English
Patent Applications Filed
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) regarding the filing of patent applications by Ananda Developments PLC. It does not fit into specific categories like financial reports, dividends, or director dealings. As it is a general corporate announcement regarding business operations (intellectual property), it falls under the 'Regulatory Filings' (RNS) category.
2023-05-17 English
Appointment of AQSE Corporate Adviser and Broker
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement regarding the appointment of a new Corporate Adviser and Broker (SP Angel) for Ananda Developments PLC. It details changes in professional advisory relationships and mentions future research coverage. Since it is a regulatory announcement regarding corporate advisory appointments and does not fit into specific categories like M&A or financial reporting, it is classified as a general regulatory filing.
2023-05-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.